Deaths from breast cancer fall in Europe, but unexplained differences between countries remain

Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy

Breast cancer screening in the UK: does it work?

EBCC 2014 key messages to doctors

Biomarker development for ipilimumab and prostate GVAX treatment

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

PSA as a marker of disease in patients with prostate cancer and bone metastases

ecancermedicalscience Editor's Choice for January 2014

MET variant as a prognostic marker in clear cell renal cell carcinoma

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Understanding the biology of the disease to guide treatment choices

Drop in breast cancer mortality in developed countries varies